Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Only a fool argues with the logic about TLT's success path
View:
Post by newdaydawning on Jul 14, 2021 3:56pm

Only a fool argues with the logic about TLT's success path

The bashers here are being paid by someone. The link to Roger and his wife is blatant.

My post was the catalyst everybody was looking for, but I could not even convince the most die-hard TLT supporters that was the case.

The science in this case is far more profound than most investors realize.

Let's keep the discussion about science and management - both important considerations in any investment.
Comment by Rumpl3StiltSkin on Jul 14, 2021 4:25pm
Let me see, BiPolar. I think you qualify NDD. Seems many of your posts in the past were either overly critical or overly bullish, and at different times... So yeah, Bipolar. Or, maybe you're part of that mythical boilerroom RW has been looking for. He certainly has reason to sue you now, even if just frivilously, ha. :-) How did you escape the last couple lawsuits?? Perhaps YOU are one of the ...more  
Comment by gebremeskel on Jul 14, 2021 4:36pm
Comment by gebremeskel on Jul 14, 2021 6:21pm
Newdaydawning, this makes absolutely no sense. Roger and his wife sue bashers they don't sponsor them. They have millions of shares they want to protect the value of. For your own sake follow the bread crumbs back to this side of the looking glass. Yes the science is ultimately what will bring value to shareholders, but the science can do nothing by itself. It needs to be implemented by a ...more  
Comment by newdaydawning on Jul 15, 2021 12:16am
Comment by newdaydawning on Jul 15, 2021 12:20am
Comment by ScienceFirst on Jul 14, 2021 9:10pm
Newdaydawning finally had nothing against TLT management.  Only plot theories.  That fits the profile of Trump muppets here.  Trump needs innocent that think he will deliver them something.  The guy is a narcissic.  Why would he care about his fanatic fans.  They simply didn't get it yet, as much as they're innocents.  Skysh!t, StevenB!tch, CaInPlap ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250